January –
Net sales: TSEK 326 (2,168).
Other operating revenues: TSEK 1,042 (0).
Profit from financial items: TSEK -14,194 (-14,617).
Earnings per share:
Cash and cash equivalents: TSEK 90,318 (120,506).
Events during the period
•
license agreement between the two companies has expired.
•
• CombiGene’s epilepsy project CG01 has been granted patent in two new countries,
Events after the end of the period
•
© Modular Finance, source